New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.

Nune A; Durkowski V; Pillay SS; Barman B; Elwell H; Bora K; Bilgrami S; Mahmood S; Babajan N; Venkatachalam S

doi:10.3390/vaccines11101571

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.

Identifier:nobleid.org/w1/20260526/08AC44C9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/08AC44C9.svg?ark=w1%2F20260526%2F08AC44C9)](https://nobleid.org/work/w1/20260526/08AC44C9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.

Identifier:nobleid.org/w1/20260526/08AC44C9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/08AC44C9.svg?ark=w1%2F20260526%2F08AC44C9)](https://nobleid.org/work/w1/20260526/08AC44C9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work